Skip to main content
. 2013 Apr 16;14(4):8291–8305. doi: 10.3390/ijms14048291

Figure 1.

Figure 1

(A) Limbal deficiency test: 1 μg of bevacizumab + 1 μg of p-PEDF-SAINT-18. No inhibition of the normal limbal vessels was noted on day 15; (B) The effect of GFP on corneal neovascularization: The 1 μg of p-SAINT-18 gene complex was implanted into the corneal stromal pocket. No limbal vessels began sprouting into the cornea on day 15.